These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4239193)

  • 1. [Effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) on the urinary excretion of osmotically free water].
    Kobinger W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):153-4. PubMed ID: 4239193
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immediate effect of 2-(2,6-dichlorophenylamino)-imidazoline (ST 155) on diuresis and renal blood output in dogs].
    Barac G
    C R Seances Soc Biol Fil; 1970; 164(11):2406-9. PubMed ID: 4257384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
    Hoefke W; Kobinger W
    Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of guancydine on fluid and electrolyte excretion: a comparison with hydralazine and reserpine.
    Gussin RZ; Stokey EH; Ronsberg MA; Malone LC; Cummings JR
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):135-51. PubMed ID: 5093183
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for a central hypotensive mechanism of 2-(2,6-dichlorophenylamino)-2-imidazoline (Catapresan, ST-155).
    Sherman GP; Grega GJ; Woods RJ; Buckley JP
    Eur J Pharmacol; 1968 Feb; 2(4):326-8. PubMed ID: 5642038
    [No Abstract]   [Full Text] [Related]  

  • 6. [Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Hukuhara T; Otsuka Y; Takeda R; Sukai F
    Arzneimittelforschung; 1968 Sep; 18(9):1147-53. PubMed ID: 5755929
    [No Abstract]   [Full Text] [Related]  

  • 7. [The action of ST 155 (2,2,6-dichlorophenylamino-2-imidazoline hydrochloride) on the hypertensive crisis induced in the rat by administration of angiotensin II].
    Pirrelli A; De Cesaris R
    Boll Soc Ital Biol Sper; 1971 Jun; 47(11):313-6. PubMed ID: 4330157
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride on the EEG arousal reaction in rabbits].
    Gogolák G; Stumpf C
    Arzneimittelforschung; 1966 Aug; 16(8):1050-2. PubMed ID: 6014886
    [No Abstract]   [Full Text] [Related]  

  • 9. On the problem of tolerance of 2-(2,6-dichlorophenylamino)-2-imidazoline.
    Walland A; Kobinger W
    Arzneimittelforschung; 1971 Jan; 21(1):61-5. PubMed ID: 5108202
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures.
    Schmitt H; Boissier JR; Giudicelli JF; Fichelle J
    Eur J Pharmacol; 1968 Mar; 2(5):340-6. PubMed ID: 5654157
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride on the blood flow of the extremities, blood pressure and venous capacity in normotensive subjects].
    Ehringer H
    Arzneimittelforschung; 1966 Sep; 16(9):1165-9. PubMed ID: 6014736
    [No Abstract]   [Full Text] [Related]  

  • 12. Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan).
    Schmitt H; Boissier JR; Giudicelli JF
    Eur J Pharmacol; 1967 Nov; 2(2):147-8. PubMed ID: 5583432
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critical considerations on the method of action of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride].
    Graubner W; Wolf M
    Arzneimittelforschung; 1966 Aug; 16(8):1055-8. PubMed ID: 6014889
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
    Gill JR; Casper AG
    J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal response to aminophylline in relation to hydration and exogenous vasopressin.
    Nechay BR
    J Pharmacol Exp Ther; 1971 Feb; 176(2):377-82. PubMed ID: 4328015
    [No Abstract]   [Full Text] [Related]  

  • 16. [Catapresan (2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride)--a new intraocular pressure lowering agent].
    Hasslinger C
    Klin Monbl Augenheilkd; 1969 Jan; 154(1):95-105. PubMed ID: 5364293
    [No Abstract]   [Full Text] [Related]  

  • 17. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action of 2-(2,6-dichlorophenylamine)2-imidazoline hydrochloride. Experimental studies in normal animals].
    Brugger A; Oliver R; Salvá JA
    Rev Esp Fisiol; 1970 Mar; 26(1):1-8. PubMed ID: 5431809
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of 2-(2,6-dichlorophenylamino)-2-imidazoline (St 155, Catapresan) on some cardiovascular reflexes in rabbits].
    Gut JP; Schmitt H
    C R Seances Soc Biol Fil; 1970; 164(4):880-3. PubMed ID: 4252165
    [No Abstract]   [Full Text] [Related]  

  • 20. Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan).
    Schmitt H; Schmitt H
    Eur J Pharmacol; 1969 Apr; 6(1):8-12. PubMed ID: 4306572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.